Emergent Biosolutions (NYSE:EBS) Announces Quarterly Earnings Results

Emergent Biosolutions (NYSE:EBS) Announces Quarterly Earnings Results

Emergent Biosolutions (NYSE:EBS - Get Free Report) issued its quarterly earnings results on Wednesday. The biopharmaceutical company reported $0.60 earnings per share for the quarter, beating analysts' consensus estimates of ($0.08) by $0.68. The company had revenue of $234.30 million during the quarter, compared to the consensus estimate of $177.50 million. Emergent Biosolutions had a negative net margin of 1.27% and a positive return on equity…